GILD: Japan's Ministry of Health, Labour and Welfare Approves Gilead's Sovaldi® (sofosbuvir) for the Treatment of Genotype 2 Chronic Hepatitis C

New alert via PocketInfo for GILD:

Japan's Ministry of Health, Labour and Welfare Approves Gilead's Sovaldi® (sofosbuvir) for the Treatment of Genotype 2 Chronic Hepatitis C

Press Releases: http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-news&nyo=0
SEC Filings: http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-sec
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8